Literature DB >> 22332132

Unusual respiratory manifestations in two young adults with Duchenne muscular dystrophy.

Julie Lemay1, Frédéric Sériès, Mario Sénéchal, Bruno Maranda, François Maltais.   

Abstract

Adult respirologists are often involved in the evaluation and treatment of young adult patients with Duchenne muscular dystrophy. In this context, the most frequent respiratory complication is nocturnal and daytime hypoventilation related to respiratory muscle weakness. The present article describes cases of Duchenne muscular dystrophy involving two brothers, 17 and 19 years of age, respectively, who presented with less frequently reported respiratory complications of their disease: obstructive sleep apnea and Cheyne-Stokes respiration with central apnea, which were believed to be partially or completely related to congestive cardiomyopathy.

Entities:  

Mesh:

Year:  2012        PMID: 22332132      PMCID: PMC3299052          DOI: 10.1155/2012/909656

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  25 in total

1.  Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy.

Authors:  Candice K Silversides; Gary D Webb; Vivien A Harris; Douglas W Biggar
Journal:  Am J Cardiol       Date:  2003-03-15       Impact factor: 2.778

2.  107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

Authors:  K Bushby; F Muntoni; J P Bourke
Journal:  Neuromuscul Disord       Date:  2003-02       Impact factor: 4.296

Review 3.  Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement.

Authors:  Jonathan D Finder; David Birnkrant; John Carl; Harold J Farber; David Gozal; Susan T Iannaccone; Thomas Kovesi; Richard M Kravitz; Howard Panitch; Craig Schramm; Mary Schroth; Girish Sharma; Lisa Sievers; Jean M Silvestri; Laura Sterni
Journal:  Am J Respir Crit Care Med       Date:  2004-08-15       Impact factor: 21.405

4.  Maximal respiratory pressures: normal values and relationship to age and sex.

Authors:  L F Black; R E Hyatt
Journal:  Am Rev Respir Dis       Date:  1969-05

5.  Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.

Authors:  L Grain; M Cortina-Borja; C Forfar; D Hilton-Jones; J Hopkin; M Burch
Journal:  Neuromuscul Disord       Date:  2001-03       Impact factor: 4.296

6.  Dilated cardiomyopathy of Becker-type muscular dystrophy with exon 4 deletion--a case report.

Authors:  M Saotome; Y Yoshitomi; S Kojima; M Kuramochi
Journal:  Angiology       Date:  2001-05       Impact factor: 3.619

7.  Dilated cardiomyopathy and new 16 bp deletion in exon 44 of the Dystrophin gene: the possible role of repeated motifs in mutation generation.

Authors:  Albena Todorova; Dimitrina Constantinova; Ivo Kremensky
Journal:  Am J Med Genet A       Date:  2003-07-01       Impact factor: 2.802

8.  Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.

Authors:  Hidemi Kajimoto; Keiko Ishigaki; Kenichi Okumura; Hirofumi Tomimatsu; Makoto Nakazawa; Kayoko Saito; Makiko Osawa; Toshio Nakanishi
Journal:  Circ J       Date:  2006-08       Impact factor: 2.993

9.  Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up.

Authors:  Denis Duboc; Christophe Meune; Bertrand Pierre; Karim Wahbi; Bruno Eymard; Annick Toutain; Carole Berard; Guy Vaksmann; Simon Weber; Henri-Marc Bécane
Journal:  Am Heart J       Date:  2007-09       Impact factor: 4.749

Review 10.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

View more
  3 in total

Review 1.  Sleep-disordered breathing in patients with neuromuscular disease.

Authors:  Mohamad Ammar Albdewi; Giuseppe Liistro; Riëm El Tahry
Journal:  Sleep Breath       Date:  2017-07-12       Impact factor: 2.816

2.  Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; M Malik; P Langa; J Cwykiel; S Brodowska; A Heydemann
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

Review 3.  Respiratory Involvement in Patients with Neuromuscular Diseases: A Narrative Review.

Authors:  Athanasios Voulgaris; Maria Antoniadou; Michalis Agrafiotis; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2019-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.